Neurobiological narratives: Experiences of mood disorder through the lens of neuroimaging

Sociology of Health and Illness

Volumn 35, Issue 1, 2013, Pages 66-81

  Buchman, Daniel Z ^a   Borgelt, Emily L ^a   Whiteley, Louise ^a,b   Illes, Judy ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Clinical translation; Neuroethics; Neuroimaging; Psychiatry; Qualitative research

Indexed keywords

EID: 85028111712     PISSN: 01419889     EISSN: 14679566     Source Type: Journal    
DOI: 10.1111/j.1467-9566.2012.01478.x     Document Type: Article

References (72)

1. Abi-Rached, J.M. and Rose, N. (2010) The birth of the neuromolecular gaze, History of the Human Sciences, 23, 1, 11-36.
2. Agarwal, N., Port, J.D., Bazzocchi, M. and Renshaw, P.F. (2010) Update on the use of MR for assessment and diagnosis of psychiatric disease, Radiology, 255, 1, 23-41.
3. Amen Clinics (2012) Success stories, available from http://www.amenclinics.net/clinics/success-stories/(last accessed 17 March 2012).
4. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (4th edition, revised text). Washington: American Psychiatric Association.
5. Angermeyer, M.C. and Matschinger, H. (2005) Labeling-stereotype-discrimination: an investigation of the stigma process, Social Psychiatry and Psychiatry Epidemiology, 40, 391-95.
6. Angermeyer, M.C., Matschinger, H. and Corrigan, P.W. (2004) Familiarity with mental illness and social distance from people with schizophrenia and major depression: testing a model using data from a representative population survey, Schizophrenia Research, 69, 2-3, 175-82.
7. Barr, M. and Rose, D. (2008) The great ambivalence: factors likely to affect service user and public acceptability of the pharmacogenomics of antidepressant medication, Sociology of Health & Illness, 30, 6, 944-58.
8. Beaulieu, A.E. (2000) The brain at the end of the rainbow: the promises of brain scans in the research field and in the media. In Marchessault, J. and Sawchuk, K. (eds) Wild Science: Reading Feminism, Medicine and the Media. London: Routledge.
9. Bennett, L., Thirlaway, K. and Murray, A.J. (2008) The stigmatising implications of presenting schizophrenia as a genetic disease, Journal of Genetic Counseling, 17, 6, 550-9.
10. Borgelt, E.L., Buchman, D.Z and Illes, J. (2011) This is why you've been suffering: reflections providers on the use of neuroimaging in mental health care, Journal of Bioethical Inquiry, 8, 1, 15-25.
11. Borry, P., Schotsmans, P. and Dierickx, K. (2005) The birth of the empirical turn in bioethics, Bioethics, 19, 1, 49-71.
12. Boyce, A.C. (2009) Neuroimaging in psychiatry: evaluating the ethical consequences for patient care, Bioethics, 23, 6, 349-59.
13. Choudhury, S., Nagel, S.K. and Slaby, J. (2009) Critical neuroscience: linking neuroscience and society through critical practice, BioSocieties, 4, 1, 61-77.
14. Cohn, S. (2010) Picturing the brain inside, revealing the illness outside: a comparison of the different meanings attributed to brain scans by scientists and patients. In Edwards, J., Harvey, P. and Wade, P. (eds) Technologized Images, Technologized Bodies. New York: Berghahn Books.
15. Corrigan, P.W., Rowan, D., Green, A., Lundin, R., et al. (2002) Challenging two mental illness stigmas: personal responsibility and dangerousness, Schizophrenia Bulletin, 28, 2, 293-309.
16. Cross, S. (2004) Visualizing madness: mental illness and public representation, Television and New Media, 5, 3, 197-216.
17. Deacon, B.J. and Baird, G.L. (2009) The chemical imbalance explanation of depression: reducing blame at what cost? Journal of Social and Clinical Psychology, 28, 4, 415-435.
18. Demirci, O., Clark, V.P., Magnotta, V.A., Andreasen, N.C., et al. (2008) A review of challenges in the use of fMRI for disease classfication/characterization and a projection pursuit application from a multi-site fMRI schizophrenia study, Brain Imaging and Behavior, 2, 3, 207-226.
19. Draper, H. and Ives, J. (2007) An empirical approach to bioethics: social science 'of''for' and 'in' bioethics research, Cognition, Brain, and Behaviour, 11, 2, 319-30.
20. Dumit, J. (2003) Is it me or my brain? Depression and neuroscientific facts, Journal of Medical Humanities, 24, 12, 35-46.
21. Fekete, D.J. (2004) How I quit being a 'mental patient' and became a whole person with a neuro-chemical imbalance: conceptual and functional recovery from a psychotic episode, Psychiatric Rehabilitation Journal, 28, 2, 189-94.
22. Foucault, M. (1972) The Archaeology of Knowledge. London: Tavistock.
23. Fournier, J.C., Derubeis, R.J., Hollon, S.D., Dimidjian, S., et al. (2010) Antidepressant drug effects and depression severity, Journal of the American Medical Association, 303, 1, 47-53.
24. Frazzetto, G. and Anker, S. (2009) Neuroculture, Nature Reviews Neuroscience, 10, 11, 815-21.
25. Fullagar, S. (2009) Negotiating the neurochemical self: anti-depressant consumption in women's recovery from depression, Health, 13, 4, 389-406.
26. Gillett, G. (2009) The Mind and Its Discontents (2nd edn). New York: Oxford University Press.
27. Glaser, B.G. and Strauss, A.Z. (1967) The discovery of grounded theory: strategies for qualitative research. Chicago: Aldine-Atherton.
28. Hacking, I. (1999) The Social Construction of What? Cambridge: Harvard University Press.
29. Hatfield, G. (2000) The brain's 'new' science: psychology, neurophysiology, and constraint, Philosophy of Science, 67, S388-403.
30. Health Canada (2002) A report on mental illnesses in Canada. Ottawa: Health Canada Editorial Board.
31. Healy, D. (2003) Let Them Eat Prozac. Toronto: Lorimer.
32. Illes, J., Lombera, S., Rosenberg, J. and Arnow, B. (2009) In the mind's eye: provider and patient attitudes on functional brain imaging, Journal of Psychiatric Research, 43, 2, 107-14.
33. Insel, T.R. and Wang, P.S. (2010) Rethinking mental illness, Journal of the American Medical Association, 303, 19, 1970-1.
34. Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., et al. (2010) Research domain criteria (RDoc): toward a new classfication framework for research on mental disorders, American Journal of Psychiatry, 167, 7, 748-51.
35. Johnson, D. (2008) 'How do you know unless you look?': brain imaging, biopower and practical neuroscience, Journal of Medical Humanities, 29, 3, 147-161.
36. Joyce, K. (2005) Appealing images: magnetic responance imaging and the production of authoritative knowledge, Social Studies of Science, 35, 3, 437-462.
37. Kirsch, I., Deacon, B.J., Huedo-Medina, T.B., Scoboria, A., et al. (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration, PLoS Medicine, 5, 2, e45.doi:10.1371/journal.pmed.0050045.
38. Kleinman, A. (1999) Moral experience and ethical reflection: can ethnography reconcile them? A quandry for 'the new bioethics', Daedalus, 128, 4, 69-97.
39. Lacasse, J.R. and Leo, J. (2005) Serotonin and depression: a disconnect between the advertisements and the scientific literature, PLoS Medicine, 2, 12, 1211-16.
40. Lefevre, W., Renn, J. and Schoepflin, U. (2003) Introduction. In Lefevre, W., Renn, J. and Schoepflin, U. (eds) The Power of Images in Early Modern Science. Berlin: Birkhauser Verlag.
41. Lincoln, Y. and Guba, E.G. (1985) Naturalistic Inquiry. Newbury Park: Sage.
42. Linden, D.E. and Fallgatter, A. (2009) Neuroimaging in psychiatry: from bench to bedside, Frontiers in Human Neuroscience, 3, 49, doi: 10.3389/neur0.09.049.2009.
43. Link, B.G., Phelan, J.C., Bresnahan, M., Stueve, A., et al. (1999) Public conceptions of mental illness: labels, causes, dangerousness, and social distance, American Journal of Public Health, 89, 9, 1328-33.
44. McCabe, D.P. and Castel, A.D. (2008) Seeing is believing: the effect of brain images on judgments of scientific reasoning, Cognition, 107, 1, 343-52.
45. Maienschein, J., Sunderland, M., Ankeny, R. and Robert, J.S. (2008) The ethos and ethics of translational research, American Journal of Bioethics, 8, 3, 43-51.
46. Marie, D. and Miles, B. (2008) Social distance and perceived dangerousness across four diagnostic categories of mental disorder, Australian and New Zealand Journal of Psychiatry, 42, 2, 126-33.
47. Martin, E. (2007) Bipolar Expeditions: Mania and Depression in American Culture. Princeton: Princeton University Press.
48. Mind Matters Clinic of Texas (2012), available from: http://www.mindmatterstexas.com/(last accessed 17 March 2012).
49. National Institute of Mental Health (2010) NIMH Research Domain Criteria (RDoC), available from http://www.nimh.nih.gov/research-funding/nimh-research-domain-criteria-rdoc.shtml (last accessed 30 January 2011).
50. Ortega, F. (2009) The cerebral subject and the challenge of neurodiversity, BioSocieties, 4, 425-45.
51. Patil, T. and Giordano, J. (2010) On the ontological assumptions of the medical model of psychiatry: philosophical considerations and pragmatic tasks, Philosophy, Ethics, and Humanities in Medicine, 5, 3, doi: 10.1186/1747-5341-5-3.
52. Pescosolido, B., Martin, J.K., Long, J.S., Medina, T.R., et al. (2010) 'A disease like any other'? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence, American Journal of Psychiatry, 167, 11, 1321-30.
53. Pfizer (2010) About EFFEXOR XR: Depression and anxiety disorders, available from http://www.effexorxr.com/effexor-xr-treatment.aspx (last accessed 13 October 2010)
54. Phelan, J. (2005) Geneticization of deviant behavior and consequences for stigma: The case of mental illness, Journal of Health and Social Behavior, 46, 4, 307-22.
55. Pickersgill, M. (2009) Between soma and society: neuroscience and the ontology of psychopathology, BioSocieties, 4, 1, 45-60.
56. Pickersgill, M. (2011) 'Promising' therapies: neuroscience, clinical practice, and the treatment of psychopathy, Sociology of Health & Illness, 33, 3, 448-64.
57. Pickersgill, M., Cunningham-Burley, S. and Martin, P. (2011) Constituting neurologic subjects: Neuroscience, subjectivity and the mundane significance of the brain, Subjectivity, 4, 3, 346-365.
58. Pitts-Taylor, V. (2010) The plastic brain: neolibralism and the neuronal self, Health, 14, 6, 635-52.
59. Racine, E., Bar-Ilan, O. and Illes, J. (2005) fMRI in the public eye, Nature Reviews Neuroscience, 6, 2, 159-64.
60. Researchware (n.d.) homepage available from http://www.researchware.com/ (last accessed 13 March 2012)
61. Rose, N. (2003) Neurochemical selves, Society, 41, 1, 46-59.
62. Rose, N. (1998) Inventing Our Selves: Psychology, Power, and Personhood. Cambridge: Cambridge University Press.
63. Roskies, A.L. (2007) Are neuroimages like photographs of the brain? Philosophy of Science, 74, 5, 860-72.
64. Roskies, A.L. (2008) Neuroimaging and inferential distance, Neuroethics, 1, 1, 19-30.
65. Schnittker, J. (2008) An uncertain revolution: why the rise of a genetic model of mental illness has not increased tolerance, Social Science & Medicine, 67, 9, 1370-81.
66. Schreiber, R. and Hartick, G. (2002) Keeping it together: How women use the biomedical explanatory model to manage the stigma of depression, Issues in Mental Health Nursing, 23, 2, 91-105.
67. Turner, E.H., Matthews, A.M., Linardotos, E., Tell, R.A. and Rosenthal, R. (2008) Selective publication of antidepressant trials and its influence on apparent efficacy, New England Journal of Medicine, 358, 3, 252-60.
68. Vidal, F. (2009) Brainhood, anthropological figure of modernity, History of the Human Sciences, 22, 1, 5-36.
69. Wetherell, M., Taylor, S. and Yates, S.J. (2007) Discourse Theory and Practice: A Reader. London: Sage.
70. Widdershoven, G., McMillan, J., Hope, T. and van der Scheer, L. ( eds ) (2008) Empirical Ethics in Psychiatry. Oxford: Oxford University Press.
71. William, S.J., Martin, P. and Gabe, J. (2011) The pharmaceuticalisation of society? A framework for analysis, Sociology of Health & Illness, 33, 5, 710-25.
72. Wood, L.A. and Kroger, R.O. (2000) Doing Discourse Analysis: Methods for Studying Action in Talk and Text. Thousand Oaks: Sage.